2014 ACR/ARHP Annual Meeting Archives - Page 202 of 202

Abstract Number: 1898

Identification of “autoinflammatory interferonopathies”? a New Class of Autoinflammatory Conditions?
Abstract Number: 1844

Identification of a Patient Phenotype Which Impacts Response to Therapy in Rheumatoid Arthritis Clinical Trials: Certolizumab Pegol Phase 4 Trial Data
Abstract Number: 1293

Identification of an Inflammation-Driven Phenotype of Osteoarthritis By Quantification of Synovial Inflammation Ex Vivo and in Serum from Patients
Abstract Number: 983

Identification of Annexin A2 As an Autoantigen in Rheumatoid Arthritis and in Lyme Arthritis
Abstract Number: 2956

Identification of Autoimmune Functional Variants Under Positive Selection in the Gullah African American Population of South Carolina
Abstract Number: 468

Identification of Baseline Risk Factors for Adverse Events in Certolizumab Pegol Treated Rheumatoid Arthritis Patients
Abstract Number: 2097

Identification of Diagnostic and Activity Metabolomic Urine Biomarkers in Six Immune-Mediated Inflammatory Diseases
Abstract Number: 652

Identification of Eat-2 As a Lupus Susceptibility Gene in New Zealand Black (NZB) Mice That Regulates Dendritic Cell Function
Abstract Number: 1131

Identification of Genetic Variants Associated with Response to Adalimumab Plus Methotrexate in Patients with Early Rheumatoid Arthritis
Abstract Number: 753

Identification of IL12RB1 As a Novel Systemic Sclerosis Susceptibility Locus
Abstract Number: 608

Identification of Novel Autoantibodies in Patients with Ankylosing Spondylitis Using Human Protein Microarray
Abstract Number: 1730

Identification of Novel Scleroderma –associated Antigens and Development of an Autoantibody Assay Panel Enabling Their Subsequent Validation
Abstract Number: 982

Identification of Potential SERUM Autoantibody Biomarkers in Rheumatic Diseases Using a New Generation of Protein Arrays
Abstract Number: 2747

Identification of Potential Serum Biomarkers for Behcet Disease By High Resolution Quantitative Proteomic Analysis
Abstract Number: 1043

Identification of Putative Biomarkers and Molecular Mechanisms Associated with Adverse Tissue Reactions to Metal-on-Metal and Modular Neck Hip Implants
Abstract Number: 76

Identification of Synovial Genes and Pathways Associated with Disease Progression in a Cohort of Early Symptomatic Osteoarthritis Patients Using a Transcriptomic Approach
Abstract Number: 1723

Identification of the Microbiome As a Potential Trigger of Systemic Sclerosis By Metagenomic RNA-Sequencing of Skin Biopsies
Abstract Number: 97

Identification of Tuberculosis in Rheumatoid Arthritis Patients Initiating Therapy with Biologic or Non-Biologic Disease-Modifying Anti-Rheumatic Drugs Using Health Insurance Claims Data
Abstract Number: 2787

Identification of Urinary Biomarkers for Lupus Nephritis
Abstract Number: 2982

Identification of Whole Blood Gene Expression Signature in Primary Sjögren’s Syndrome Associated Lymphoma
Abstract Number: 1055

Identifying Flare in Rheumatoid Arthritis (RA): Performance of the Flare-Assessment in RA (FLARE) Questionnaire in a US Population
Abstract Number: 2841

Identifying Novel Lupus Severity Risk Variants through Identification of Alleles with High Ethnic Variability Worldwide
Abstract Number: 1668

Identifying Patient Perceptions of Medication Decision Making Barriers in Minorities with Lupus Nephritis
Abstract Number: 1604

IFN-γ (Th₁), IL4 (Th₂), and IL5 (Th₂) Are Elevated in Pre-Clinical SLE and Predict Transition to Classified Disease Prior to Appearance of Autoantibodies or Clinical Criteria
Abstract Number: 2863

IgG Antiphospholipid Antibodies Enhance Stroke Damage: An in Vivo Ischemia/Reperfusion Study
Abstract Number: 1236

IgG4 Immunostaining Is Common but Not Specific in Orbitbal Inflammatory Diseases
Abstract Number: 2805

IgG4-Related Disease: Baseline Features in 100 Patients with Biopsy-Proven Disease
Abstract Number: 326

IL-1 Receptor Antagonis (IL-1Ra)-Fc Ameliorate Autoimmune Arthritis By Regulation of the Th17 Cells/Treg Balance and Arthrogenic Cytokine Activation
Abstract Number: 1915

IL-17 Gene Transfer induces Myeloid Precursor Cells That Initiate Epidermal Hyperplasia Independently of IL-23R⁺/CD4⁺ and γδ T Cells
Abstract Number: 1914

IL-17A Deficiency Promotes Periosteal Bone Formation in a Model of Inflammatory Arthritis
Abstract Number: 1042

IL-1β and TNF-α Promote Monocyte Viability through the Induction of GM-CSF Expression By Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 1734

IL-22 Plays a Significant Role in the Initiation and Augmentation of Th17-Dependent Experimental Arthritis
Abstract Number: 1459

IL-22 Secreted By NKp44+NK Cells Promote the Proliferation of Synovium in Patients with Rheumatoid Arthritis By Activation of STAT3
Abstract Number: 1917

IL-23 Expression and Activation of Autophagy in Synovium and PBMCs of HLA-B27 Positive Patients with Ankylosing Spondylitis
Abstract Number: 632

IL-23 Mediates Psoriasis-like Inflammation in the SKG Mouse Model of Spondyloarthropathy
Abstract Number: 374

IL-33 and Soluble ST2 Levels As Novel Predictors for Remission and Progression of Carotid Plaque in Early Rheumatoid Arthritis: A Prospective Study
Abstract Number: 2801

IL-38: A New Factor in Rheumatoid Arthritis
Abstract Number: 1906

IL-6 Blockade Reduces Circulating N-Terminal Pro-Brain Natriuretic Peptide Levels in Patients with Active Rheumatoid Arthritis
Abstract Number: 2455

IL-6 Proximal Promoter SNP rs18000795 Genotype Strongly Correlates with Synovial Fibroblast IL-6 Expression
Abstract Number: 1714

IL-6 Trans-Signalling Activates M2 Macrophage Polarisation and Mediates Fibrotic Response in Scleroderma
Abstract Number: 994

IL-7 Modulates B Cell Immunoglobulin Isotype Production and Increases B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) in Synovial Fibroblasts from Osteoarthritis (OA) and Rheumatoid Arthritis (RA) Patients
Abstract Number: 1918

IL23 Overexpression Demonstrates Gut-Joint Inflammation Link and Increased Expression of Spondyloarthopathy Associated Genes In Vivo
Abstract Number: 2564

Ileocolonoscopic Findings in the Korean Patients with Ankylosing Spondylitis
Abstract Number: 1318

Illness Onset Features and Misdiagnosis in Juvenile Idiopathic Inflammatory Myopathies (JIIM) Differ Among Clinical and Autoantibody (Ab) Subgroups
Abstract Number: 1041

Imaging the Role of Chemoattractants in Inflammatory Arthritis
Abstract Number: 1736

Immune Related Adverse Events Associated with Anti-CTLA-4 Antibodies: Systematic Review and Meta-Analysis
Abstract Number: 2275

Immunization Status and Barriers in Childhood Rheumatic Diseases
Abstract Number: 1501

Immunogenicity Assessment of PF-06438179, a Potential Biosimilar to Infliximab, in Healthy Volunteers
Abstract Number: 446

Immunoglobulin a Antibodies to Cyclic Citrullinated Protein Predominate in Individuals at-Risk for Future Rheumatoid Arthritis
Abstract Number: 2162

Immunological Abnormalities in Adult Patients with Parvovirus B19 Infection : A study of 23 Cases
Abstract Number: 633

Immunological and Clinical Relationships of Synovial IL-17+ T Cells in Psoriatic Arthritis
Abstract Number: L12

Immunological Phenotyping of a Cohort of American Travelers with Chikungunya Viral Arthritis
Abstract Number: 1733

Immunomodulatory Effects of Dietary Non-Digestible Oligosaccharides in T Cell-Mediated Autoimmune Arthritis
Abstract Number: 1739

Immunomodulatory Properties of CD271+ and CD271- Synovial Mesenchymal Cells
Abstract Number: 1109

Impact of Age on Symptom Severity and Disease Management at Fibromyalgia Diagnosis
Abstract Number: 1508

Impact of Anti-Drug Antibody on Efficacy and Safety over Week 24 in Both CT-P10 and Innovator Rituximab Treatment Groups
Abstract Number: 1479

Impact of Clinical Remission on Physical Function in Patients with Rheumatoid Arthritis Treated with ALX-0061: Post-Hoc Analysis of Phase I/II Data
Abstract Number: 99

Impact of Comorbidities on Health Resource Utilization in Patients with Spa
Abstract Number: 2504

Impact of Concomitant Methotrexate on the Enhanced Clinical Efficacy of Abatacept after 24 Weeks in Rheumatoid Arthritis Patients
Abstract Number: 1397

Impact of Corticosteroid Use on Remission Sustainability and Infection Rates Among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on a Real-World Canadian Population
Abstract Number: 1436

Impact of Depression on Clinical and Social Outcomes in Patients with Rheumatoid Arthritis: Comparative Study in Germany and Brazil
Abstract Number: 65

Impact of Dropout and Total Knee Replacement on Joint Space Narrowing Estimation: Data from Osteoarthritis Initiaive
Abstract Number: 2912

Impact of Failure to Adhere to Treat-to-Target of Rheumatoid Arthritis in Real World Practice: Data from the International Rheumatoid Arthritis Biomarker Program
Abstract Number: 1123

Impact of Genes Modulating Serum Low-Density Lipoprotein Cholesterol Levels on Progression of Joint Destruction in Japanese Patients with Rheumatoid Arthritis
Abstract Number: 733

Impact of Geographic Variation on the Risk of Digital Ulcers Development in Systemic Sclerosis: A Brazilian Multicenter Registry
Abstract Number: 2671

Impact of Glucocorticoid Dose on Maternal and Fetal Outcomes in Lupus Pregnancies
Abstract Number: 2495

Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials
Abstract Number: 1430

IMPACT of Initiative to Control Cardiovascular Risk Factors in Collaboration with LOCAL Doctors in Patients with Rheumatoid Arthritis
Abstract Number: 683

Impact of Lupus on Work Productivity in Patients and Caregivers: Findings from a Cross-Sectional Online Survey in the United States
Abstract Number: 1371

Impact of Metabolic Syndrome (MetS) on Rheumatoid Arthritis Disease Activity
Abstract Number: 1062

Impact of Obesity on 1 Year Outcomes: Results from the Meteor Foundation International Rheumatoid Arthritis Cohort
Abstract Number: 824

Impact of Oral Glucocorticoid Therapy on Mortality in Patients with Rheumatoid Arthritis and Diabetic Mellitus
Abstract Number: 682

Impact of Patient’s Priorities on the Management of Systemic Lupus Erythematosus
Abstract Number: 2368

Impact of Physicians’ Adherence to Treat-to-Target Strategy on Outcomes in Early Rheumatoid Arthritis
Abstract Number: 2624

Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population
Abstract Number: 1362

Impact of Rapid Attainment of Stringent Measures of Efficacy in Rheumatoid Arthritis on Patient-Reported Outcomes
Abstract Number: 2597

Impact of Repeating Imaging of the Sacro-Iliac Joints over One Year on the Classification According the ASAS Axial Spa Criteria of Patients
Abstract Number: 1069

Impact of Rheumatoid Arthritis on the Mortality of Patients Who Develop Cancer: A Population-Based Study
Abstract Number: 1522

Impact of Sarilumab on Health Related Quality of Life (HRQoL), Fatigue, and Sleep in Rheumatoid Arthritis Patients at Week 24 – Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
Abstract Number: 709

Impact of Sleep Disorders in Quality of Life, Pain and Disease Activity Using Actigraphy and Pittsburgh Sleep Quality Index (PSQI)in Female with Systemic Lupus Ertyhematosus (SLE).
Abstract Number: 2618

Impact of Ustekinumab on Active Inflammation and Post-Inflammatory Structural Changes As Detected By Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis: Results of a 28-Week, Prospective, Open-Label, Proof-of-Concept Study
Abstract Number: 29

Impaired Bone Healing in Patients Suffering from Rheumatoid Arthritis – Anti-Inflammatory Therapy As Confounder
Abstract Number: 2550

Impaired Speckle Tracking As a Marker of Subclinical Left Ventricular Dysfunction in Patients Affected By Primary Sjögren’s Syndrome
Abstract Number: 198

Implant Survival and Patient-Reported Outcomes after Total Hip Arthroplasty in Young Patients with JIA
Abstract Number: 1984

Implementation and Performance of an Objective Structured Clinical Examination (OSCE) in a National Certification Process of Trainees in Rheumatology. Two Years of Experience
Abstract Number: 2002

Implementation of a Collaborative Rheumatology and Physiatry Musculoskeletal Ultrasound Training Program
Abstract Number: 1519

Implementation of an Acid Dissociation Procedure for Immunogenicity Detection in Patients Treated with ANTI-TNF Drugs
Abstract Number: 1447

Implementing American College of Rheumatology (ACR) Quality Indicators for Rheumatoid Arthritis (RA) in the United Arab Emirates (UAE)
Abstract Number: 1810

Improper Use of Antinuclear Antibody (ANA) Test Can Result in Misdiagnosis, Increased Patient Anxiety, and Wasted Health Care Resources
Abstract Number: 226

Improved Prediction of Hip Fracture Using the Health Assessment Questionnaire-Disability Index and FRAX^® in Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Study
Abstract Number: 2968

Improvement Following Total Knee Replacement (TKR) Surgery: Exploring Preoperative Symptoms and Change in Preoperative Symptoms
Abstract Number: 1996

Improvement in Basic Bone Health Knowledge Among VA Primary Care Practitioners during a Focused Musculoskeletal Mini-Residency
Abstract Number: 1348

Improvement in Herpes Zoster Vaccination and Documentation for Rheumatoid Arthritis Patients Using Electronic Medical Record
Abstract Number: 1690

Improvement of Digital Ulcerative Disease in Patients with Systemic Sclerosis Is Associated with Better Functional Prognosis
Abstract Number: L5

Improvement of Disease Activity and Reduction of Severe Flares Following Subcutaneous Administration of an IL-6 Monoclonal Antibody (mAb) in Subjects with Active Generalized Systemic Lupus Erythematosus (SLE)
Abstract Number: 2397

Improvement of Fatigue in Patients with Rheumatoid Arthritis Treated with Biologics: Relationship with Sleep Disorders, Depression and Clinical Efficacy. a Prospective, Multicenter Study
Abstract Number: 2093

Improvement of Rituximab Response Prediction in Rheumatoid Arthritis Via Correction for Prednisone-Related Suppression of Type I Interferon Response Gene Expression
Abstract Number: 332

Improvement of the Stability of RNA Aptamers Against Interleukin-17A
Abstract Number: 2811

Improvements in Rheumatoid Arthritis Related Fatigue Are Driven By Reductions in Pain, Not Disease Activity – Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Abstract Number: 943

Improvements in the Proportion of Patients Achieving DAS, CDAI, and SDAI Remission By Omitting the Patient Global Assessment (PtGA): an Analysis from a Prospective, Observational Registry
Abstract Number: 2310

Improving Access to Health Care in Rheumatology Practices through Initiation of an Outpatient Urgent Care Clinic, a Paradigm Shift
Abstract Number: 1357

Improving Compliance for Tuberculosis Screening for Patients on Biologics in Rheumatology Clinics
Abstract Number: 471

Improving of Safety in Treatment with Biologics during First Seven-Years Experiences; Long-Term Results from Observational Cohort Study of Clinical Practice Using Multicenter Registry in Japan
Abstract Number: 1445

Improving Osteoarthritis Outcomes Utilizing a Multidisciplinary Model of Care; Experience in a Diverse Multicultural Urban Teaching Hospital
Abstract Number: 1345

Improving Pneumococcal Immunization Rates for Patients on Immunosuppressant Medications at an Academic Rheumatology Clinic
Abstract Number: 1983

Improving Resident Confidence with the Musculoskeletal Exam through a Rheumatology-Dedicated Musculoskeletal Workshop
Abstract Number: 2305

Improving Screening for Hyperlipidemia in Patients with Rheumatoid Arthritis at an Academic Rheumatology Practice
Abstract Number: 1342

Improving Serologic Testing for Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
Abstract Number: 1354

Improving the Measurement of Disease Activity for Patients with Rheumatoid Arthritis: Validation of an Electronic Version of the Routine Assessment of Patient Index Data (RAPID 3)
Abstract Number: 453

In a Periodontal Disease Cohort without RA, Indeterminate or Low-Positive Anti-CCP-2 Antibodies Are Associated with Multiple Distinct ACPA
Abstract Number: 367

In Early Rheumatoid Arthritis Patients with Non-Response to Methotrexate Monotherapy the Change in Multi-Biomarker Disease Activity Score Is Differentially Associated with Subsequent Response to Non-Biological Versus Biological Therapy
Abstract Number: 364

In Early Rheumatoid Arthritis, the Multi-Biomarker Disease Activity Score at Different Time-Points Is Predictive of Subsequent Radiographic Progression
Abstract Number: 380

In Palindromic Rheumatism, Older Age, Shorter Interval Between Attacks and Positive Anti-CCP Antibodies May Predict Progression to RA
Abstract Number: 616

In Situ Analysis of Mechanisms of New Bone Formation in Zygapophyseal Joints from Patients with Ankylosing Spondylitis
Abstract Number: 1943

In Vivo Effects of Epratuzumab, a Monoclonal Antibody Targeting Human CD22, on B Cell Function in Human CD22 Knock-in (Huki) Mice
Abstract Number: 1892

In Vivo Visualization of Cortical Microchannels in Metacarpal Bones in Patients with Cutaneous Psoriasis By High Resolution Peripheral Computed tomography – Detecting Cortical Pathologies before the Clinical Onset of Psoriatic-Arthritis
Abstract Number: 2188

Incidence and Mortality of Relapsing Polychondritis in the United Kingdom: A Population-Based Cohort Study
Abstract Number: 2037

Incidence and Prevalence of Myasthenia Gravis in Rheumatoid Arthritis Patients with and without Treatment Compared with the General Population
Abstract Number: 50

Incidence and Risk Factors for Osteoporotic Vertebral Fracture in Low-Income Community-Dwelling Elderly: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health (SPAH) Study
Abstract Number: 1506

Incidence of Adverse Events in Patients Treated with Intended Copies of Biologic Therapeutic Agents in Colombia and Mexico
Abstract Number: 485

Incidence of Clinical and Serological Lupus-like Disease during Anti-Tnfα-Treatment – a Two-Year Prospective Study in an Interdisciplinary Patient Cohort
Abstract Number: 1909

Incidence of Congestive Heart Failure in Subjects with Rheumatoid Arthritis Receiving Anti-Tumour Necrosis Factor Drugs: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Abstract Number: 482

Incidence of Opportunistic Infections in Rheumatoid Arthritis Treated with Biological Agents
Abstract Number: 785

Incidence, Prevalence and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy
Abstract Number: 818

Incident Rheumatoid Arthritis and Risk of Mortality Among Women Followed Prospectively from 1976 to 2010 in the Nurses’ Health Study
Abstract Number: 1994

Incorporation of Musculoskeletal Ultrasound Curriculum and 6-Month Assessment of Knowledge Retention into the 2nd Year of Medical Student Training
Abstract Number: 177

Increase in Thyroid Stimulating Hormone (TSH) Levels in Patients with Gout Treated with Inhibitors of Xanthine-Oxido-Reductase
Abstract Number: 1852

Increased Cardiovascular Risk in Patients Recently Diagnosed with Psoriatic Arthritis: A Population-Based, Cohort Study
Abstract Number: 1623

Increased CD95 (Fas) Expression on Naive B Cells Is Associated with a Switch to Double Negative and Plasma Cells in the Peripheral Blood, and Correlates with Disease Activity in Systemic Lupus Erythematosus
Abstract Number: 755

Increased Degradation of BMPR2 in a TGFβ Dependent Transgenic Mouse Model of Scleroderma with Susceptibility to Pulmonary Arterial Hypertension
Abstract Number: 2939

Increased Diagnosis of Spondyloarthritis in Female Patients Started in the Early Biologic Era
Abstract Number: 748

Increased Expression of Chemerin in Endothelial Cells Due to Fli1 Deficiency May Contribute to the Development of Digital Ulcers in Systemic Sclerosis
Abstract Number: 1956

Increased IL-6 Production By Effector B Cells in Giant Cell Arteritis and Polymyalgia Rheumatica
Abstract Number: 2224

Increased Immune Complex Levels in Children with Juvenile Dermatomyositis Are Not Associated with Levels of Von Willebrand Factor Antigen, C4, Duration of Illness, Disease Activity Score, or the Absolute NK Count
Abstract Number: 355

Increased Left Ventricular Mass Index and Decreased Ejection Fraction Are Associated with Disease Activity in Rheumatoid Arthritis Patients without Cardiac Symptoms; Comparison Between Non-Biologic and Biologic Dmards Treatment Groups, Using a Cardiac Magnetic Resonance Imaging
Abstract Number: 783

Increased Migration and Proliferation Potential Characterize Vascular Smooth Muscle Cells from Patients with Giant Cell Arteritis
Abstract Number: 1804

Increased Mortality in Ankylosing Spondylitis – Results from a National Population Based Study
Abstract Number: 1713

Increased Number of CD206⁺cells in Peripheral Blood and Skin of Systemic Sclerosis Patients
Abstract Number: 1443

Increased Occurence of Carotid and Femoral Plaques, but Not Increased Arterial Stiffness of Hypertrophy, in Classical Risk Factor-Free Patients with Rheumatoid Arthritis
Abstract Number: 363

Increased Prevalence of Plasma Anti-Nuclear, Anti-SSA, and Connective Tissue Disease Associated Antibodies in African American Patients with Rheumatoid Arthritis
Abstract Number: 1770

Increased Risk of Chronic Obstructive Pulmonary Disease in Granulomatosis with Polyangiitis: A General Population-Based Study
Abstract Number: 2932

Increased Risk of Deep Vein Thrombosis and Pulmonary Embolism in Sjögren’s Syndrome: A General Population-Based Cohort Study
Abstract Number: 2664

Increased Risk of Hematological Malignancies in Children Born to Women with SLE
Abstract Number: 1865

Increased Risk of Myocardial Infarction and Cerebrovascular Accidents after Diagnosis of Granulomatosis with Polyangiitis: A General Population-Based Cohort Study
Abstract Number: 915

Increased Risk of Myocardial Infarction in Dermatomyositis and Polymyositis: A General Population-Based Cohort Study
Abstract Number: 2761

Increased Risk of Parenchymal Neurological Involvement in Behcet’s Syndrome Patients with Panuveitis
Abstract Number: 2466

Increased Risk of Rheumatoid Arthritis (RA) Among Shared Epitope-Negative (SE-) Mothers with Shared Epitope-Positive (SE+) Children
Abstract Number: 170

Increased Risk of Skin Reactions with Gout Medications: An Analysis of VA Databases
Abstract Number: 354

Increased Vascular Wall Inflammation in Patients with Active Rheumatoid Arthritis As Measured By an 18F-FDG-PET/CT Scan
Abstract Number: 488

Increases in Serum Cholesterol with Baricitinib Treatment Are Associated with Favorable Changes in Apolipoprotein Content and with Improvement in DAS28-CRP in Patients with Rheumatoid Arthritis
Abstract Number: 1932

Increasing Access to Inflammatory Arthritis Education in Rural and Remote Communities Using Telemedicine
Abstract Number: 436

Increasing Cartilage Turnover in Smokers Developing Rheumatoid Arthritis Is Associated with High Disease Activity in Early Disease
Abstract Number: 199

Increasing Complexity of Patients Undergoing Primary Total Hip Arthroplasty in the U.S
Abstract Number: 1154

Increasing Discrepancies Between Physician Assessment of Disease Activity and Patient Global Health in Germany Between 2000 and 2012
Abstract Number: 227

Increasing Fat-Mass May Reverse Bone Loss As Detected By DXA Scan
Abstract Number: 2318

Increasing Rates of Remission in Juvenile Idiopathic Arthritis through a Quality Improvement Learning Network – the Pediatric Rheumatology Care and Outcomes Improvement Network
Abstract Number: 1822

Increasing Synovitis and Bone Marrow Lesions Are Associated with Incident Joint Tenderness in Hand Osteoarthritis
Abstract Number: 2501

Indirect Comparison of Tocilizumab and Tofacitinib in Patients with Rheumatoid Arthritis
Abstract Number: 609

Induced Pluripotent Stem Cells (iPSCs) As a Tool for Unraveling the Role of Different Cell Types in the Disease Process of Spondyloarthritis Pathogenesis
Abstract Number: 2837

Induction of Clinical Remission By Low-Dose Interleukin-2 in Refractory SLE
Abstract Number: 1031

Induction of Pro-Apoptotic Noxa Expression By Ursolic Acid Sensitizes Rheumatoid Arthritis Synovial Fibroblasts to Apoptosis: A Role of Mir-181a
Abstract Number: 1164

Inequity: Level of Education Is Associated with Access to Biologic Dmards Even in a Country with Highly Developed Social Welfare (Norway)
Abstract Number: 462

Infections and Gastrointestinal Side Effects in a Comparison of Rheumatoid Arthritis Therapies
Abstract Number: 1196

Inflammation Develops in a Toll-like Receptor 9-Independent Manner in Experimental Arthritis and Rheumatoid Arthritis
Abstract Number: 1823

Inflammation Is Associated with Erosive Progression in Patients with Hand Osteoarthritis: A Prospective Ultrasonography Study
Abstract Number: 334

Inflammatory Arthritis in K/BxN Mice Is Associated with Abnormal HDL Function
Abstract Number: 2115

Inflammatory Arthritis Treatment Outcomes at a First Nations Reserve Rheumatology Specialty Clinic
Abstract Number: 1581

Inflammatory Back Pain in Psoriasis and Psoriatic Arthritis Is Suggestive of Undiagnosed Spondyloarthropathies
Abstract Number: 1408

Inflammatory Biomarkers, Sleep Quantity and Sleep Quality in Rheumatoid Arthritis
Abstract Number: 597

Inflammatory Burden in Recent-Onset Axial Spondyloarthritis
Abstract Number: 2891

Inflammatory Genes Are Associated with Autoantibodies in Rheumatoid Arthritis-Free Individuals Who Are at-Risk for Future Disease
Abstract Number: 1962

Inflammatory Properties of Inhibitor of DNA Binding 1 As a Unique Fibroblast Derived Nuclear Protein
Abstract Number: 2983

Infliximab Added to Naproxen Does Not Increase Frequency of New Fatty Lesions on MRI of the Sacroiliac Joints and of the Spine As Compared to Naproxen Alone in Early Axial Spondyloarthritis
Abstract Number: 2525

Infliximab Versus Conventional Combination Treatment and Work Loss in Early RA over 7 Years: A Randomized Trial
Abstract Number: 1876

Influence of Alcohol Consumption on the Risk of SLE Among Women in the Nurses’ Health Studies
Abstract Number: 680

Influence of Antimalarial doesn´t Modify the Outcome of Cytopenias in Systemic Lupus Erythematosus
Abstract Number: 393

Influence of Body Mass Index on Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis : A Systematic Review and Meta-Analysis
Abstract Number: 1663

Influence of Ethnicity on Efficacy of Current Immunosuppressive Protocols in Proliferative Lupus Nephritis
Abstract Number: 1431

Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study
Abstract Number: 777

Influence of the IL17A Locus in Giant Cell Arteritis Susceptibility
Abstract Number: 74

Influence of the Polymorphism IL1ß (-511 A/C) and IL6 (- 174 G/C) on the Activity, Radiographic Damage and Clinical Forms of Patients with Psoriatic Arthritis (PSA)
Abstract Number: 1489

Influences of Disease Activity at the Initiation of Iguratimod, a Small Molecule Antirheumatic Drug, on Efficacy of Iguratimod in Patients with Rheumatoid Arthritis –a Multicenter Registry Study-
Abstract Number: 648

Influenza A (H1N1) Virus Infection Triggers Severe Pulmonary Inflammation in Lupus-Prone Mice Following Viral Clearance
Abstract Number: 30

Inhibiting Autocrine Interleukin-6 (IL-6) Trans-Signalling in Human CD14^+VE Monocultures Reduces Osteoclast Differentiation
Abstract Number: 651

Inhibiting Tweak (TNF-like weak inducer of apoptosis) Signaling Improves Blood Brain Barrier Integrity and Protects from Neuronal Damage in Murine Neuropsychiatric Lupus
Abstract Number: 860

Inhibition of G Protein βγ Signaling Inhibits Nephritis in Lupus Prone Mice
Abstract Number: 311

Inhibition of Natural Killer (NK) Cell Cytotoxicity By Interleukin-6 (IL-6): Implications for the Pathogenesis of Macrophage Activation Syndrome
Abstract Number: 2917

Inhibition of PAD4 Activity and the Formation of Neutrophil Extracellular Traps Via PTPN22, but Not Its Rheumatoid Arthritis-Prone W620 Variant
Abstract Number: 2320

Initial Benchmarking of the Quality of Medical Care of Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1678

Initial Therapy with an Endothelin Receptor Antagonist Is Associated with Worse Outcomes in Patients with Systemic Sclerosis and Pulmonary Arterial Hypertension: Observations from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Cohort
Abstract Number: 620

Innate Immune Stimulation Triggers Altered IL-1a/b Gene Expression and Experimental Spondyloarthritis in HLA-B27/huβ2m Transgenic Rats
Abstract Number: 802

Inpatient Complications in Patients with Giant Cell Arteritis: Increased Risk of Thromboembolism, Delirium and Adrenal Insufficiency
Abstract Number: 2277

Inpatient Pediatric Rheumatic Diseases: Characteristics, Cost and Trends
Abstract Number: 899

Insurance Status and U.S. Region Associated with Placement of Permanent Vascular Access in Dialysis Patients with End-Stage Renal Disease Secondary to Lupus Nephritis
Abstract Number: 986

Integrated Comprehensive Analysis of Immune Cell Subsets and Serum Protein Profile Identifies the Role of Pre-Germinal Center B Cells in Sjogren’s Syndrome Pathogenesis
Abstract Number: 1556

Integrated Safety of Ustekinumab in Psoriatic Arthritis: 2 Year Follow-up from the Psoriatic Arthritis Clinical Development Program
Abstract Number: 1353

Integrating Collection of Rheumatoid Arthritis Disease Activity and Physical Function Scores into an Academic Rheumatology Practice to Improve Quality of Care
Abstract Number: 2477

Integrating Treatment Goals of Physicians, Patients, and Payers during Treatment with Golimumab in Patients with Rheumatoid Arthritis
Abstract Number: 1991

Integration of Nailfold Capillary Microscopy and Dermoscopy into the Rheumatology Fellows Curriculum
Abstract Number: 1885

Integrative Omics Profiling Reveals Dysregulated Novel Pathways Mediated By microRNAs and DNA Methylation in Osteoarthritis
Abstract Number: 744

Integrin Inhibitor Modulates Pulmonary Fibrosis in the Reactive Oxygen Species Murine Model of Systemic Sclerosis
Abstract Number: 130

Inter-Rater Reliability of the US-7 Score in a Population of Volunteers: Is a Post-Hoc Analysis of Still Images Comparable to the Dynamic Analysis? Results from the German “Rheuma-Truck” Cohort
Abstract Number: 1798

Interaction Between Innate Immunity and Anti-Ro52 Antibodies is Critical for the Induction of Sjogren’s Syndrome-like Disease in Mice
Abstract Number: 2045

Interaction Effects Between Genes and Blood Lead Level on a Composite Score of Multiple Joint Symptoms: The Johnston County Osteoarthritis Project
Abstract Number: 31

Interaction of FGF-8 and TNF-a in the Regulation of BMP-Induced Osteoblast Differentiation
Abstract Number: 1959

Interaction of PDE4 and β-Arrestin Reverses Anti-Inflammatory Effects of Catecholamine-Producing Cells in Chronic Arthritis Via Adrenoceptor Switching from Gαs to GαI Signalling
Abstract Number: 2161

Interest of Systematic Lyme Serology in Context of Recent Onset Arthritis
Abstract Number: 2760

Interferon Alfa-Associated Depression in Patients with Behçet’s Syndrome
Abstract Number: 1619

Interferon Dysregulation in an Academic SLE Cohort Is Associated with Distinct Signaling Differences in Blood Neutrophils Versus PBMCs
Abstract Number: 1645

Interferon Gene Signature Expression and Serological Differences in Japanese and Non-Japanese SLE Patients
Abstract Number: 662

Interferon Regulatory Factor-5 Promotes Disease in the MRL/Lpr Mouse Model of Lupus
Abstract Number: 1625

Interferon Stimulates Transglutaminase Activity on Human Monocytes and Their Microparticles
Abstract Number: 872

Interferon-α and Angiogenic Dysregulation in Pregnant Lupus Patients Destined for Preeclampsia
Abstract Number: 1901

Interferon-γ (IFNγ) in Macrophage Activation Syndrome (MAS) Associated with Systemic Juvenile Idiopathic Arthritis (sJIA). High Levels in Patients and a Role in a Murine MAS Model
Abstract Number: 884

Interleukin 6 Does Not Upregulate Pro Inflammatory Cytokine Expression in an Ex-Vivo Model of Giant Cell Arteritis
Abstract Number: 2237

Interleukin-1 Dual-Variable Domain Immunoglobulin Reduces Multiple Inflammatory Markers in Knee Osteoarthritis Patients
Abstract Number: 2876

Interleukin-10 Receptor Blockade during Lcmv Infection Results in Macrophage Activation Syndrome-like Disease in Mice
Abstract Number: 834

Interleukin-18 (IL-18) As a Biomarker for Diagnosis and Evaluation of Disease Activity in Patients with Adult Onset Still’s Disease and Systemic Onset Juvenile Idiopathic Arthritis
Abstract Number: 1039

Interleukin-20 Is Triggered By TLR Ligands and Associates with Rheumatoid Arthritis Disease Activity
Abstract Number: 335

Interleukin-33 Suppresses Experimental Arthritis through Promoting Foxp3⁺ Regulatory T-Cells and Type-2 Immune Responses in Mice
Abstract Number: 1006

Interleukin-4 As Promising, Anti-Inflammatory Transgene for Gene Therapeutic Application in Joint Diseases
Abstract Number: 2241

Intermittent Analgesic Use and Risk of Pain Exacerbation in Knee Osteoarthritis: A Web Based Case-Crossover Study
Abstract Number: 1999

Internal Medicine Resident Confidence in Rheumatologic and Musculoskeletal Diseases: A Needs Assessment Survey
Abstract Number: 727

International Classification of Functioning, Disability, and Health (ICF) Core Sets for Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) and Idiopathic Pulmonary Fibrosis (IPF) – a Necessary Map to Health Care Provision in the Era of ICD-11
Abstract Number: 2953

International Immunochip Study in the Idiopathic Inflammatory Myopathies Identifies Novel Susceptibility Loci and Confirms HLA As Strongest Genetic Risk Factor
Abstract Number: 2401

Interrupted and Delayed Care in First Nation Patients with Rheumatoid Arthritis: The Best Target for Therapy?
Abstract Number: 2996

Intestinal Pseudo-Obstruction in Patients with Systemic Sclerosis: An Analysis of the Nationwide Inpatient Sample
Abstract Number: 295

Intra-Articular Corticosteroid Injections in Juvenile Idiopathic Arthritis: Results from a UK Prospective Collaborative Study
Abstract Number: 2844

Intracellular Complement C3 Is Exposed on the Cell Surface upon Apoptosis Induction and Participates in the Clearance of Apoptotic Cells By Phagocytes
Abstract Number: 2199

Intravenous Immunoglobulin Therapy for Secondary Hemophagocytic Lymphohistiocytosis : A Retrospective Study of 46 Patients
Abstract Number: 1252

Intravenous Methylprednisolone Pulse Therapy in Severe Inflammatory Eye Disease. a Multicenter Study
Abstract Number: 2191

Intravenous Sodium Thiosulfate for Treatment of Refractory Calcinosis in Rheumatic Disease
Abstract Number: 2181

Investigating Myeloid and Plasmacytoid Dendritic Cell Activation within the Synovium and Peripheral Blood of Rheumatoid Arthritis Patients
Abstract Number: 2182

Investigating the Roles of Factor H-Related Proteins in Systemic Lupus Erythematosus (SLE) and Other Autoimmune Diseases
Abstract Number: 1721

Investigating the SCF/c-Kit Pathway in Scleroderma Fibrosis
Abstract Number: 429

Investigation of MRI Bone Changes in Early-Stage RA Patients Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort
Abstract Number: 2326

Investigation of Parameters Used to Test Quadriceps Muscle Power Using Isokinetic Dynamometer in Arthritis
Abstract Number: 1414

Investigation of the Association Between Gastroesophageal Reflux Disease and Clinical Factors in Patients with Rheumatoid Arthritis
Abstract Number: 2069

Investigation of the Effects of Physical Exercise on the Control Mechanisms of Cutaneous Circulation in Patients with Fibromyalgia Syndrome
Abstract Number: 1812

Investigation of the Sting/Interferon Pathway Activation in a Novel Vasculopathy and Pulmonary Syndrome
Abstract Number: 2849

Involvement of CD8⁺ T Cells in the Pathogenesis of Giant Cell Arteritis and Polymyalgia Rheumatica
Abstract Number: 1746

Involvement of IL-17-Producing MAIT Cells in the Pathogenesis of Rheumatoid Arthritis
Abstract Number: 1228

Involvement of the IFN-Õ Pathway in a Patient with Candle Syndrome Carrying a Novel Variant of PSMB8 Gene
Abstract Number: 529

IP3R3 Deficit Underlies the Loss of Fluid Secretion in Salivary Glands from Sjögren’s Syndrome Patients
Abstract Number: 762

IQGAP1 Enhances Contractility of Scleroderma Lung Fibroblasts and Promotes Bleomycin-Induced Pulmonary Fibrosis
Abstract Number: 870

IRF1 Influences on Histone H4 Acetylation in Systemic Lupus Erythematosus
Abstract Number: 1130

IRF8 Gene Contributes to Disease Susceptibility and Interacts with NF-KB By Modulating Interferon Signature in Patients with Systemic Sclerosis
Abstract Number: 228

Is Adult Hypophosphatasia a Cardiovascular Risk Factor?
Abstract Number: 2936

Is Ankylosing Spondylitis a Risk Factor for Cardiovascular Diseases, and How Does These Risks Compare to Those in Rheumatoid Arthritis?
Abstract Number: 169

Is Gout a Coronary Heart Disease Risk Equivalent, Similar to Diabetes?
Abstract Number: 278

Is It Worth Allowing the Presence of Morning Stiffness in the Definition of Inactive Disease in Juvenile Idiopathic Arthritis?
Abstract Number: 1894

Is It Worth It to Include MRI of the Spine in the ASAS Classification Criteria for Axial Spondyloarthritis?
Abstract Number: 1632

Is Liopxin A4 a Biomarker for Systemic Lupus Erythematosus?
Abstract Number: 1239

Is Lymphocytic Sialadenitis IgG4-Related?
Abstract Number: 1229

Is NOD2-Associated Autoinflammatory Disease Remotely Related to Familial Mediterranean Fever or Continuum of It?
Abstract Number: 1339

Is Psychological Status Related to Symptom Experience in Behçet’s Syndrome?
Abstract Number: 2417

Is Remission Really Achievable in EARLY Rheumatoid Arthritis?
Abstract Number: 842

Is Rheumatoid Arthritis a Coronary Heart Disease Risk Equivalent, Similar to Diabetes?
Abstract Number: 2812

Is Rheumatoid Arthritis the Same Disease in Women and Men?- Joint Damage in Patients with EARLY Rheumatoid Arthritis at 10 YEARS after Diagnosis
Abstract Number: 202

Is Schuss View Alone Enough for the Diagnosis of Femorotibial Osteoarthritis ? the Khoala Cohort Study
Abstract Number: 116

Is Socioeconomic Status at Diagnosis Associated with Long-Term Direct Medical Costs in Systemic Sclerosis? a General Population-Based Cohort Study
Abstract Number: 2073

Is Susceptibility to Fibromyalgia a Trait?
Abstract Number: 1809

Is Team Care Better? a Comparison of Rheumatoid Arthritis Disease Activity Among Patients Cared for in Practices with Nurse Practitioners and Physicians Assistants Versus Rheumatologist Only
Abstract Number: 792

Is Temporal Artery Biopsy the Gold Standard for the Diagnosis of Giant Cell Arteritis?
Abstract Number: 248

Is the Basdai Score Driven By Pain in Ankylosing Spondylitis Patients Treated with Anti-TNF?
Abstract Number: 2556

Is the Degree of NSAID Treatment in Early Axial Spondyloarthritis a Reflection of the physician’s Diagnosic Confidence? Results from the DESIR Cohort
Abstract Number: 711

Is the Disease-Specific Lupusqol Sensitive to Changes of Disease Activity in SLE Patients after Treatment of a Flare?
Abstract Number: 224

Is the Protective Effect of Obesity Against Hip Fracture Due to Changes of Proximal Femur Shape?
Abstract Number: 163

Is the Rate of Skin Reactions to Febuxostat Increased in Patients with a History of Skin Intolerance to Allopurinol? a Retrospective, Hospital-Based Study Involving 101 Patients Consecutively Treated with Allopurinol and Febuxostat
Abstract Number: 2480

Is there a Difference in the Effectiveness in the Treatment of Rheumatoid Arthritis with Rituximab when Using a Dose of 1 or 2 Grams per Cycle? a Systematic Review
Abstract Number: 1600

Is There a Role for Inflammasome Activation in PsA Pathogenesis and Its Comorbidities?
Abstract Number: 3

Is There an Association Between Persistently High Positive Antiphospholipid Antibody Profile and Organ Damage Accrual in Lupus Patients?
Abstract Number: 2507

Is There an Autoinflammatory Component in Rheumatoid Arthritis Associated with Better Response to Anakinra (Kineret^®)?
Abstract Number: 599

Is There Any Gender Specific Difference in the Cut Off Values of Ankylosing Spondylitis Disease Activity Score (ASDAS) in Patients with Axial Spondyloarthritis?